Afamelanotide (AFA) is a synthetic analogue of α-melanocyte-stimulating hormone that is approved for the treatment of patients affected by erythropoietic protoporphyria (EPP)....
Leggi tuttoThe presence of peripheral globules is associated with enlarging melanocytic lesions...
Leggi tuttoTreatment of Grover Disease With Dupilumab...
Leggi tuttoAntimicrobial resistance (AMR) is a global health emergency....
Leggi tuttoTo investigate if the combination of biologics with methotrexate (MTX)...
Leggi tuttoAtopic dermatitis (AD) is a common yet complex skin disease, posing a therapeutic challenge with increasingly recognized different phenotypes among variable patient populations....
Leggi tuttoVitiligo is an autoimmune skin condition characterized by depigmented macules and patches, and has a huge psychosocial impact on patients....
Leggi tuttoAlthough topical minoxidil is an effective treatment option for hair loss...
Leggi tuttoErosive lichen planus affecting the vulva and vagina (ELPV)...
Leggi tuttoThe COVID-19 pandemic required the setting of a national lockdown in Italy from March 9, 2020, until May 18, 2020...
Leggi tuttoScalp lichen simplex chronicus (LSC) is rare and can be a challenging and frustrating condition for both patient and physician....
Leggi tuttoThe SARS-CoV-2 pandemic has worsened since publication...
Leggi tuttoDermoscopy of Syringotropic and Folliculotropic Mycosis Fungoides...
Leggi tuttoA 48-week update of a multicentre real-life experience of dupilumab in adult patients...
Leggi tuttoCOVID-19 is associated with a wide range of skin manifestations....
Leggi tuttoHidradenitis suppurativa (HS) is a chronic, recurrent, inflammatory skin disease involving the follicular unit....
Leggi tuttoSince the best clinical response to dupilumab is achieved after 12-16 weeks...
Leggi tuttoTechnological advances in medicine have brought about many novel skin imaging devices....
Leggi tuttoRisultati da 261 a 280 di 709